Human papillomavirus vaccine TH-GW - Japan Vaccine/Xenova

Drug Profile

Human papillomavirus vaccine TH-GW - Japan Vaccine/Xenova

Alternative Names: Genital warts vaccine - Japan Vaccine/Xenova; Human papillomavirus vaccine TA-GW - Japan vaccine/Xenova; TA-GW; TH-GW

Latest Information Update: 20 Apr 2017

Price : $50

At a glance

  • Originator Xenova Group
  • Class Papillomavirus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Human papillomavirus infections

Most Recent Events

  • 18 Oct 2000 Discontinued-II for Human papillomavirus infections in Australia (IM)
  • 18 Oct 2000 Discontinued-II for Human papillomavirus infections in Canada (IM)
  • 18 Oct 2000 Discontinued-II for Human papillomavirus infections in New Zealand (IM)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top